X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carbapenemase-producing enterobacteriaceae (464) 464
index medicus (369) 369
infectious diseases (272) 272
microbiology (262) 262
humans (261) 261
klebsiella-pneumoniae (150) 150
pharmacology & pharmacy (148) 148
escherichia-coli (134) 134
enterobacteriaceae (130) 130
anti-bacterial agents - pharmacology (100) 100
beta-lactamases - genetics (97) 97
male (91) 91
bacteria (90) 90
epidemiology (88) 88
microbial sensitivity tests (86) 86
female (78) 78
carbapenemase (77) 77
antimicrobial resistance (76) 76
emergence (74) 74
enterobacteriaceae infections - microbiology (72) 72
hospitals (70) 70
beta-lactamases - metabolism (69) 69
drug resistance in microorganisms (69) 69
public, environmental & occupational health (69) 69
infections (68) 68
aged (66) 66
anti-bacterial agents - therapeutic use (65) 65
middle aged (65) 65
resistance (65) 65
drug resistance (64) 64
enterobacteriaceae - enzymology (62) 62
gram-negative bacteria (62) 62
spread (62) 62
antibiotics (61) 61
bacterial proteins - genetics (60) 60
klebsiella pneumoniae (60) 60
prevalence (60) 60
research (59) 59
enterobacteriaceae - isolation & purification (57) 57
beta-lactamase (55) 55
adult (54) 54
klebsiella infections - microbiology (54) 54
biochemical phenomena, metabolism, and nutrition (53) 53
enterobacteriaceae infections - epidemiology (53) 53
metallo-beta-lactamase (51) 51
carbapenemase-producing (50) 50
risk factors (49) 49
colonization (48) 48
enterobacteriaceae - drug effects (48) 48
infectious disease (48) 48
klebsiella pneumoniae - genetics (48) 48
outbreak (48) 48
aged, 80 and over (47) 47
genes (47) 47
health aspects (47) 47
antibiotic-resistance (46) 46
pneumonia (45) 45
pseudomonas-aeruginosa (45) 45
drug resistance, multiple, bacterial (44) 44
surveillance (44) 44
enterobacteriaceae - genetics (43) 43
klebsiella pneumoniae - isolation & purification (42) 42
identification (41) 41
klebsiella pneumoniae - drug effects (41) 41
molecular epidemiology (41) 41
antimicrobial agents (40) 40
bacterial infections and mycoses (39) 39
bacterial proteins - metabolism (38) 38
beta-lactamases (38) 38
klebsiella infections - epidemiology (38) 38
plasmids (38) 38
beta lactamases (37) 37
blood-stream infections (37) 37
escherichia coli (37) 37
mortality (36) 36
bacterial pneumonia (35) 35
intensive-care-unit (35) 35
oxa-48 (35) 35
carbapenemases (34) 34
infectious and parasitic diseases (34) 34
kpc (34) 34
rapid detection (34) 34
drug resistance, bacterial (33) 33
carbapenem-resistant enterobacteriaceae (32) 32
esbl (32) 32
infection (32) 32
infection control (32) 32
multilocus sequence typing (32) 32
resistant enterobacteriaceae (32) 32
cross infection - epidemiology (31) 31
in-vitro activity (31) 31
klebsiella pneumoniae - enzymology (31) 31
medicine (31) 31
polycyclic compounds (31) 31
colistin (30) 30
lactamase-producing enterobacteriaceae (30) 30
nosocomial infections (30) 30
risk-factors (30) 30
analysis (29) 29
e coli (29) 29
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 05/2015, Volume 277, Issue 5, pp. 501 - 512
The prevalence of carbapenem‐resistant Gram‐negative bacilli is on the rise worldwide, posing a major public health threat. Previously, this was mostly a... 
Klebsiella pneumoniae carbapenemase | combination therapy | carbapenemase | carbapenemase‐producing Enterobacteriaceae | New Delhi metallo‐β‐lactamase | colistin | Carbapenemase | Colistin | Combination therapy | Carbapenemase-producing enterobacteriaceae | New delhi metallo-β-lactamase | MULTIDRUG-RESISTANT | New Delhi metallo--lactamase | PREVALENCE | EMERGENCE | carbapenemase-producing Enterobacteriaceae | MEDICINE, GENERAL & INTERNAL | THERAPEUTIC OPTIONS | COLISTIN METHANESULFONATE | MOLECULAR EPIDEMIOLOGY | SPREAD | CRITICALLY-ILL PATIENTS | KLEBSIELLA-PNEUMONIAE | Klebsiella Infections - enzymology | Klebsiella Infections - drug therapy | Klebsiella Infections - prevention & control | Enterobacteriaceae Infections - prevention & control | Global Health | Humans | beta-Lactamases - biosynthesis | Communicable Disease Control - methods | Enterobacteriaceae Infections - enzymology | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Bacterial Proteins - biosynthesis | Klebsiella pneumoniae | Enterobacteriaceae Infections - drug therapy | beta-Lactam Resistance - drug effects | Pneumonia | Drug resistance | Health aspects | Antibacterial agents | Bacterial pneumonia | Infection control | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 10/2019, Volume 63, Issue 10
Carbapenem-resistant Enterobacteriaceae (CRE) can be mechanistically classified into carbapenemase-producing Enterobacteriaceae (CPE) and... 
carbapenem-resistant Enterobacteriaceae | risk factors | carbapenem resistance | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EMERGENCE | carbapenemase-producing Enterobacteriaceae | ADULT INPATIENTS
Journal Article
Journal Article
Journal of Clinical Nursing, ISSN 0962-1067, 11/2019, Volume 28, Issue 21-22, pp. 3890 - 3900
Aim To explore patients' accounts of screening and being managed for colonisation with the antimicrobial resistant organism, carbapenemase‐producing... 
infection prevention and control | antimicrobial resistance | carbapenemase‐producing Enterobacteriaceae | hospital screening | patient experience | qualitative
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2018, Volume 62, Issue 11
Journal Article
BMC Microbiology, ISSN 1471-2180, 04/2018, Volume 18, Issue 1, pp. 38 - 8
Background: Carbapenemases-producing Enterobacteriaceae (CPE) are a worldwide public health emergency. In Mexico, reports of CPE are limited, particularly in... 
NDM-1 | Pediatrics | OXA-232 | KPC-2 | Carbapenemase-producing Enterobacteriaceae | Mexico | OXA-48 | RESISTANT ENTEROBACTERIACEAE | INFECTIONS | ESCHERICHIA-COLI | GLOBAL DISSEMINATION | MICROBIOLOGY | TREATMENT OPTIONS | METALLO-BETA-LACTAMASE | ANTIMICROBIAL SURVEILLANCE PROGRAM | SPREAD | KLEBSIELLA-PNEUMONIAE | Klebsiella pneumoniae - isolation & purification | Carbapenem-Resistant Enterobacteriaceae - isolation & purification | Klebsiella oxytoca - genetics | Enterobacter cloacae - enzymology | Humans | Child, Preschool | Hospitals, Pediatric | Infant | Male | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Klebsiella oxytoca - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - enzymology | Carbapenem-Resistant Enterobacteriaceae - genetics | Escherichia coli - pathogenicity | Klebsiella pneumoniae - genetics | Female | beta-Lactamases - metabolism | Child | Latin America - epidemiology | Enterobacter cloacae - genetics | Escherichia coli - enzymology | Mexico - epidemiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae Infections - mortality | Genotype | Klebsiella oxytoca - isolation & purification | Enterobacteriaceae Infections - physiopathology | Enterobacter cloacae - pathogenicity | Molecular Epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Klebsiella oxytoca - enzymology | Klebsiella pneumoniae - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - pathogenicity | Adolescent | Klebsiella pneumoniae - enzymology | Enterobacter cloacae - isolation & purification | Enterobacteriaceae infections | Colistin | Escherichia coli | Beta lactamases | Dosage and administration | Research | Drug therapy
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 2, pp. 153 - 163
Journal Article